Browse by Poster Presenter

Skip to main content

ICPE 2023 Main banner

ICPE 2023 Program

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Presenter

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

K
Kahrs, Jacob

UNC Gillings School of Global Public Health
(151) A Safety Comparison of Continuing Versus Discontinuing Triptans for Acute Migraine Treatment in Early Pregnancy
Jacob Kahrs
Favorite
Kalesinskas, Laurynas

Flatiron Health, Inc
(241) Unlocking the patient journey: comparing machine learning (ML) based natural language processing (NLP) and expert abstraction in understanding treatment patterns
Laurynas Kalesinskas
Favorite
Kalloo, Geetika

Carelon Research
(185) Descriptive Characteristics and Validation of Fibrotic Interstitial Lung Disease Patients (ILD) with and without progression Using a Claims Based Algorithm
Geetika Kalloo
Favorite
Kamada, Yuta

Division of Biostatistics, Tohoku University Graduate School of Medicine
(175) Burden of Narcolepsy from the Perspectives of Direct Medical Cost and Comorbidity in Japan
Yuta Kamada
Favorite
Kamauu, Aaron

Navidence
(217) Development of Computable Operational Definitions to Maximize Comparability & Consistency Across a Multi-Data Source Global Real-World Effectiveness Program
Aaron Kamauu
Favorite
Kandikatla, Renuka

School of Pharmacy MCPHS University
(151) PRO Reporting and Methodological Rigor in NSCLC RCTs, a Cause for Concern
Renuka Kandikatla
Favorite
Kaplan, Sigal

Teva Pharmaceutical Industries Ltd
(121) Pregnancy and Fetal Outcomes Following Paternal Exposure to Glatiramer Acetate
Sigal Kaplan
Favorite
(123) Pregnancy and Fetal Outcomes Following Maternal Exposure to Glatiramer Acetate in 3 Trimesters of Pregnancy
Sigal Kaplan
Favorite
(170) Prevalence and Incidence of Multiple System Atrophy in Real World Setting: Results from US Claims Database
Sigal Kaplan
Favorite
Kassandros, Konstantinos

Democritus University of Thrace
(204) Predicting Drug Consumption in Relation to Respiratory Diseases: An Analysis of the National Organisation for the Provision of Health Services ( EOPYY) Dataset in Greece
Konstantinos Kassandros
Favorite
Keebler, Daniel

Regeneron Pharmaceuticals
(051) Background rates of cardiovascular events in patients at high risk of severe COVID-19 before and during the COVID-19 pandemic
Daniel Keebler
Favorite
Kejlberg Al-Mashhadi, Sofie

Aarhus University, Department of Clinical Epidemiology
(170) The Clinical Presentation of and Mortality in Stroke Patients Using Glucocorticoids
Sofie Kejlberg Al-Mashhadi
Favorite
Kendrick, Katherine

Pfizer Inc
(242) Analysis of SARS-CoV-2 Testing Patterns Post-PAXLOVID TM Prescription Orders and Analysis of Patients with Multiple PAXLOVID Prescription Orders
Katherine Kendrick
Favorite
Khachatryan, Artak

Certara Ltd., UK
(163) Quality of Life of Patients with Mild Cognitive Impairment or Alzheimer's Disease and Their Caregivers in the United States
Artak Khachatryan
Favorite
Kim, EunYoung

Chung-Ang University
(005) A Real-world Evidence on Electrolyte Disorders with Piperacillin/Tazobactams :Using the FARES Database over 10 years
EunYoung Kim
Favorite
Kim, Hee-Jin

Ewha Womans University
(266) Changes in vaccination patterns for infants after the introduction of DTaP-IPV/Hib combination vaccines
Hee-Jin Kim
Favorite
Kim, Jeong Ah

Department of Health Convergence, College of Science & Industry Convergence, Ewha Womans University, Seoul, Republic of Korea
(B16) Immunization Status of the 23-Valent Pneumococcal Polysaccharide Vaccine among Elderly Aged 65 and Older in South Korea
Jeong Ah Kim
Favorite
Kim, Jeong-Yeon

College of Pharmacy, Chung-Aug University
(221) Incidence of Active Tuberculosis According to Latent Tuberculosis Infection Treatment Before Targeted Therapy in Patients with Rheumatoid Arthritis
Jeong-Yeon Kim
Favorite
Kim, Jun Hyeob

College of Pharmacy, Chungbuk National University, Cheongju, Republic of Korea
(198) Factors associated with Type2 Diabetes Mellitus development based on Korean National Health Insurance Sharing Service data
Jun Hyeob Kim
Favorite
Kim, Ki Yeon

School of Pharmacy, Sungkyunkwan University, South Korea
(012) Safety of using nirmatrelvir/ritonavir and cardiovascular medications with potential drug-drug interactions: Comparative safety analysis using WHO international database
Ki Yeon Kim
Favorite
Kim, Stella

Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University
(137) Trends in the Utilisation of Antiepileptic Drugs Following Ischaemic Stroke
Stella Kim
Favorite
Kim, Sujin

University of Kentucky
(249) Detecting digital illness threat using an anomaly detection approach in the United States
Sujin Kim
Favorite
Kim, Tae Young

College of Pharmacy, Chungbuk National University, Cheongju, Republic of Korea
(235) Statin use and sensorineural hearing loss in patients with type 2 diabetes: Evidence from a population-based case-control study
Tae Young Kim
Favorite
Kirakoya-Samadoulougou, Fati

Centre de Recherche en Épidémiologie, Biostatistique et Recherche Clinique, École de Santé Publique, Université Libre de Bruxelles, Bruxelles, Belgique
(051) Monitoring of adverse events during seasonal malaria chemoprevention campaigns in children aged 3-59 months in Burkina Faso: A real-world evidence
Fati Kirakoya-Samadoulougou
Favorite
(052) Adverse post-vaccination events reported with anti-COVID-19 vaccines in Burkina Faso: analysis of spontaneous reports
Fati Kirakoya-Samadoulougou
Favorite
Kirk, Brenna

Aetion, Inc
(069) Identification and characterization of patients receiving a 1st booster of COVID-19 vaccines in a US administrative database
Brenna Kirk
Favorite
(089) Clinical characteristics and healthcare resource utilization among patients identified with post-acute sequelae of COVID-19 (long-COVID) in US administrative claims data
Brenna Kirk
Favorite
Kirui, Brian

School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
(103) Impact of chronic oral glucocorticoid treatment on mortality in patients with COVID-19 - An analysis from a population-based cohort within the SCIFI-PEARL project
Brian Kirui
Favorite
Knox, Caitlin

Regeneron Pharmaceuticals, Inc.
(238) The Prevalence of Aortic Stenosis and Aortic Valve Replacement in the United States: A Retrospective Descriptive Claims Study
Caitlin Knox
Favorite
Kolla, Epiphane

EPI-PHARE (Scientific Interest Group in Epidemiology of Health Products), French National Agency for the Safety of Medicines and Health Products, French National Health Insurance, CEDEX, 93285 Saint-Denis, France
(133) Immunosuppressive therapy and covid-19-related hospitalization in solid organ transplant recipients: a French nationwide cohort study
Epiphane Kolla
Favorite
Kollhorst, Bianca

Leibniz Institute for Prevention Research and Epidemiology - BIPS
(031) Medical Scandal with illegally diluted Chemotherapy in Germany: Prognosis of Patients with Breast and non-solid Cancers
Bianca Kollhorst
Favorite
(103) Identification of Pregnancies Without a Recorded Outcome in German Claims Data
Bianca Kollhorst
Favorite
Kostka, Kristin

Northeastern University & University of Oxford
(109) Long COVID symptoms following primo- vs reinfection: a multinational cohort analysis of primary care records from Catalonia and the UK
Kristin Kostka
Favorite
(182) Characterizing Real-World Data Usage for Public Health Research
Kristin Kostka
Favorite
Kponee-Shovein, Kalé

Analysis Group, Inc., Boston, MA, USA
(228) Development of a risk categorization framework to quantify antimicrobial resistance risk in female patients with uncomplicated urinary tract infection
Kalé Kponee-Shovein
Favorite
Kristin, Erna

Department of Pharmacology and Therapy, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Indonesia
(B04) Direct Medical Cost Associated with Antiplatelet Non-persistence in Acute Coronary Syndrome Patients After Percutaneous Coronary Intervention
Erna Kristin
Favorite
Ku, Jennifer

Kaiser Permanente Southern California
(299) Effectiveness of a Fourth Dose of mRNA-1273 Vaccine Against COVID-19 Among Older Adults in the United States
Jennifer Ku
Favorite
Kuk, Deborah

Inspire
(163) A Novel Patient-Centered Real-World Evidence Study Designed to Better Understand Short Bowel Syndrome Using Longitudinal Data in the United States
Deborah Kuk
Favorite
kumar R, Mahendra

School of Pharmaceutical Science, Lovely Professional University
(248) A safety Review of Clinical Adverse Events Associated with Cardiovascular Medical Devices under Materiovigilance
Mahendra kumar R
Favorite
Kumar, Vikas

OMNY Health
(075) Reasons for Treatment Alteration in Dermatology Patients: Insights from Unstructured Clinical Notes
Vikas Kumar
Favorite
Kunhikatta, Vijayanarayana

Department of Pharmacy practice, Manipal college of pharmaceutical sciences,Manipal Academy of Higher Education,Manipal, Karnataka, India
(280) Comparison of presepsin and interleukin 6 for the diagnosis of neonatal sepsis: a systematic review and meta-analysis
Vijayanarayana Kunhikatta
Favorite
Kuo, Yong-Fang

University of Texas Medical Branch
(033) Prescription Sequence Symmetry Analysis of Administrative Claims Data for Detection of Opioid Use Adverse Events
Yong-Fang Kuo
Favorite
(211) Pain control associated with opioid and gabapentinoid prescription after elective knee replacement
Yong-Fang Kuo
Favorite
Kuranz, Seth

Forian, Inc
(A46) Progression to ESRD Among White, Black and Hispanic Diabetic Kidney Disease Patients: Real-World Evidence from Multiple Linked Claims Databases
Seth Kuranz
Favorite